Skip to content

PalliSupport: a transitional care pathway for elderly patients at the end of life

PalliSupport: a transitional care pathway for elderly patients at the end of life

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON28511
Enrollment
600
Registered
2018-12-10
Start date
2019-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Palliative care

Interventions

A transtional palliative care pathway. The transitional care pathway starts during admission and follows patients both in primary and secondary care.

Sponsors

Amsterdam UMC, location AMC
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Age (≥65 years); 2) Acutely admitted for ≥48 hours to the departments of internal medicine, geriatrics, cardiology, pulmonary disease, gastroenterology or oncology; 3) Positive SPICT™ criteria: a hospital admission in six months prior to admission,functional status decline and weight loss (65-79 years: two or more positive criteria, >80 years: 1 or more positive criteria); 4) Ability to read and speak the Dutch language;

Exclusion criteria

Exclusion criteria: Patients who are not able to answer questionnaires due to severe cognitive impairment (MMSE<15) due to diagnosis of dementia or active delirium during the entire admission, will be excluded. Furthermore, patients who live far from the hospital and therefore cannot be visited by the palliative care team will be excluded.

Design outcomes

Primary

MeasureTime frame
Number of patients with an unplanned hospitalisation in the six months after inclusion.

Secondary

MeasureTime frame
Death at place of (first) preference; palliative care outcomes (POS/USD/ESAS); Quality of Life (EQ5D/McGill Quality of Life Questionnaire; Informal caregiver burden (CareQol); Healthcare utilization; Costeffectiness analysis and processevaluaton

Contacts

Public ContactBianca Buurman

Postbus 22660

b.m.vanes@amc.nl+31 (0)20 5665991

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)